Ascent Group’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.23M Buy
11,879
+2,672
+29% +$239K 0.04% 358
2026
Q1
$661K Buy
9,207
+123
+1% +$9.47K 0.02% 443
2025
Q4
$721K Buy
9,084
+2,184
+32% +$172K 0.02% 429
2025
Q3
$520K Buy
6,900
+160
+2% +$11K 0.02% 496
2025
Q2
$465K Sell
6,740
-599
-8% -$39.3K 0.02% 485
2025
Q1
$497K Buy
+7,339
New +$439K 0.02% 460
2024
Q3
Sell
-20,188
Closed -$1.19M 528
2024
Q2
$1.19M Buy
20,188
+2,578
+15% +$161K 0.1% 247
2024
Q1
$1.4M Buy
17,610
+14,693
+504% +$1.12M 0.12% 233
2023
Q4
$225K Buy
+2,917
New +$208K 0.02% 464
2023
Q3
Sell
-5,842
Closed -$432K 461
2023
Q2
$432K Sell
5,842
-2,700
-32% -$192K 0.05% 327
2023
Q1
$635K Sell
8,542
-2,074
-20% -$174K 0.07% 281
2022
Q4
$989K Sell
10,616
-1,686
-14% -$163K 0.12% 221
2022
Q3
$1.17M Sell
12,302
-2,613
-18% -$259K 0.14% 196
2022
Q2
$1.43M Sell
14,915
-3,217
-18% -$314K 0.17% 179
2022
Q1
$1.83M Sell
18,132
-1,127
-6% -$118K 0.21% 167
2021
Q4
$1.96M Buy
+19,259
New +$1.78M 0.25% 149

Other funds holding CVS

Ascent Group's CVS Position: Q2 2026 in Review

Ascent Group increased its CVS Health (CVS) stake by 29% in Q2 2026, buying an estimated $239K and bringing the position to 11,879 shares worth $1.23M. The position accounts for 0.04% of the portfolio, ranked #358.

Ascent Group first reported a position in CVS in Q4 2021 and has held it in 16 quarters since. The position peaked at $1.96M in Q4 2021. 2,067 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Ascent Group held 11,879 shares of CVS Health worth $1.23M as of Q2 2026.
  • Ascent Group bought 2,672 CVS Health shares in Q2 2026, an estimated $239K.
  • CVS Health made up 0.04% of Ascent Group's portfolio in Q2 2026, its #358 holding.
  • Ascent Group first reported a position in CVS Health in Q4 2021 and has held it in 16 quarters since.
  • Ascent Group's CVS Health position peaked at $1.96M in Q4 2021.
  • 2,067 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Ascent Group's 13F filing for Q2 2026, filed 3 Aug 2026.